Synthesize Bio
Synthesize Bio develops generative genomics models that predict how human tissues and cells respond to drugs, diseases, and experimental interventions. Its platform enables drug development teams, clinical development teams, and biopharma partners to simulate clinical trial outcomes, optimize trial design, identify biomarkers, and augment limited datasets with virtual human cohorts. The organization aims to accelerate and de-risk clinical development by providing actionable predictions and insights grounded in large-scale RNA-seq data.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology Research
- Founded
- 2023
- Type
- Corporation Seattle business license
- Employees
- 21
- Registered name
- Synthesize Bio Seattle business license
- Stage
- Seed
- Founders
- Robert Bradley, PhD, Jeff Leek, PhD
Is this your organization? Claim it
AI House hosts Demo Day in Seattle with 25 startups pitching to investors flown in from Boston, New York, Colorado and the Bay Area
AI House hosted a demo day in Seattle where 25 early-stage startups—many outside the incubator’s portfolio—pitched to investors flown in from Boston, New York, Colorado, the Bay Area and other cities to increase outside capital for local founders. Organizers aimed to showcase diverse Seattle startups, from revenue-generating companies to ambitious technologists, and attracted both national and local venture investors.
Taylor Soper lists founders and startups who pitched at Demo Day, including Lightspeed AI, Vantari VR, Eidol AI and Hubble AI (YC S26)
A LinkedIn post by Taylor Soper lists founders who pitched at Demo Day, naming thirty individuals and teams along with their startups, including companies like Lightspeed AI, Vantari VR, Eidol AI, and Hubble AI (YC S26).
Seattle Startup Pauling.AI Uses AI to Cut Drug Discovery from Months to Weeks, Founded by Ex-Google Exec Javier Tordable in 2024
Seattle startup Pauling.AI uses AI to automate early drug discovery steps, reducing timelines from months to weeks and aiming to greatly increase new drug approvals. Founded in 2024 by former Google technical director Javier Tordable, the company offers a 'scientist-as-a-service' platform to assist researchers with computational chemistry and drug candidate modeling.
See all 5 news stories about Synthesize Bio.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Jeff Leek Co-founder, Co-CEO
-
Alice M. Walsh Executive, COO